Published in Int J Endocrinol on February 18, 2014
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med (1993) 102.56
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet (1998) 34.34
Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract (2009) 25.83
Obesity. Lancet (2005) 17.67
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med (1994) 16.24
Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med (2000) 10.05
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (2010) 9.20
Mechanisms linking obesity with cardiovascular disease. Nature (2006) 9.07
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis (2007) 8.79
Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83
The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68
Diagnosis and classification of diabetes mellitus. Diabetes Care (2009) 7.66
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Biological action of leptin as an angiogenic factor. Science (1998) 6.02
The burden of mortality attributable to diabetes: realistic estimates for the year 2000. Diabetes Care (2005) 5.80
The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med (1993) 5.61
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia (2001) 4.78
A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem (1983) 4.39
The 14-year incidence of visual loss in a diabetic population. Ophthalmology (1998) 4.08
Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol (2003) 2.74
The role of inflammatory cytokines in diabetes and its complications. J Periodontol (2008) 2.39
Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia (1995) 2.27
Perspectives on diabetic retinopathy. Am J Ophthalmol (2003) 2.22
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care (2001) 2.11
Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) (2005) 2.05
Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am (2010) 2.02
Changing prevalence of overweight children and adolescents at onset of insulin-treated diabetes. Diabetes Care (2003) 2.01
Diabetic retinopathy. A clinical overview. Diabetes Care (1992) 1.61
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59
Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk In Communities study. Invest Ophthalmol Vis Sci (2004) 1.56
Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology (1997) 1.50
Elevated serum vascular endothelial growth factor is associated with visceral fat accumulation in human obese subjects. Diabetologia (2003) 1.44
Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1997) 1.35
Mortality risk by body weight and weight change in people with NIDDM. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetes Care (1995) 1.26
The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care (2003) 1.25
Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care (2008) 1.18
Complications of type 1 diabetes. Endocrinol Metab Clin North Am (2010) 1.18
The epidemic of type 1 diabetes: what is it telling us? Curr Opin Endocrinol Diabetes Obes (2011) 1.17
C-reactive protein, body mass index, and diabetic retinopathy. Invest Ophthalmol Vis Sci (2010) 1.14
Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius. Am J Epidemiol (1998) 1.12
Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndrome. Mediators Inflamm (2013) 1.11
Association of obesity with diabetic retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SN-DREAMS Report no. 8). Acta Diabetol (2009) 1.11
Angiogenic growth factors and their inhibitors in diabetic retinopathy. Curr Diabetes Rev (2010) 1.09
Are obesity and anthropometry risk factors for diabetic retinopathy? The diabetes management project. Invest Ophthalmol Vis Sci (2011) 1.07
The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Coll Antropol (2013) 1.02
Impact of overweight on chronic microvascular complications in type 1 diabetic patients. Diabetes Care (2005) 1.00
The metabolic syndrome in type 1 diabetes: does it exist and does it matter? J Diabetes Complications (2008) 0.97
Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese Type 2 diabetic subjects. Diabet Med (2004) 0.95
Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications. Diabetes Res Clin Pract (2007) 0.90
Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm (2013) 0.89
Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment. Exp Ther Med (2013) 0.87
Evaluation of accuracy of 20 different test kits for the enzymic determination of cholesterol. Clin Chem (1983) 0.86
Is leptin associated with diabetic retinopathy? Diabetes Care (2000) 0.85
Aspects of inflammation and oxidative stress in pediatric obesity and type 1 diabetes: an overview of ten years of studies. Exp Diabetes Res (2012) 0.85
Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm (2013) 0.85
The association between the HLA system and retinopathy development in patients with type 1 diabetes mellitus. Coll Antropol (2013) 0.83
Different risk factors of microangiopathy in patients with type I diabetes mellitus of short versus long duration. The EURODIAB IDDM Complications Study. Diabetologia (2000) 0.82
Adiponectin as a marker of complications in type I diabetes. Indian Pediatr (2011) 0.81
Relationship between diabetic retinopathy, microalbuminuria and overt nephropathy, and twenty-year incidence follow-up of a sample of type 1 diabetic patients. J Diabetes Complications (2012) 0.81
Maternal immune system adaptation to pregnancy--a potential influence on the course of diabetic retinopathy. Reprod Biol Endocrinol (2010) 0.80
Circulating adiponectin is associated with renal function independent of age and serum lipids in west africans. Int J Nephrol (2012) 0.80
Inflammation and pharmacological treatment in diabetic retinopathy. Mediators Inflamm (2013) 1.00
Diagnostic procedures and management of dry eye. Biomed Res Int (2013) 0.91
Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes. Mediators Inflamm (2013) 0.89
Body mass index: a risk factor for retinopathy in type 2 diabetic patients. Mediators Inflamm (2013) 0.85